New heart pump trial offers hope for advanced heart failure patients

NCT ID NCT06907017

Recruiting now Disease control Sponsor: CorWave Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 04, 2026 · Updated 2 times

Summary

This study tests a new heart pump (CorWave LVAS) in 20 people with advanced heart failure. The pump helps the heart pump blood when it is too weak. The goal is to see if the device is safe and works well, with a focus on survival and avoiding serious problems like bleeding, infection, or stroke. Participants will be followed for 30 days after the pump is placed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

advanced heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED HEART FAILURE

Contacts and locations

Locations

Bayside Health
RECRUITING

Melbourne, Victoria, 3004, Australia
St Vincent's Hospital Sydney
RECRUITING

Sydney, New South Wales, 2010, Australia
University Medical Center Heart Center
RECRUITING

Astana, 010000, Kazakhstan

More trials for these conditions

Other studies related to the condition(s) this trial covers.